EQ
USDEquillium Inc. Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$0.351
Haut
$0.390
Bas
$0.351
Volume
0.22M
Fondamentaux de l'Entreprise
Capitalisation Boursière
13.8M
Industrie
Biotechnologie
Pays
United States
Statistiques de Trading
Volume Moyen
0.36M
Bourse
NCM
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
Leerink Partners Downgrades Equillium to Market Perform, Lowers Price Target to $1
Leerink Partners analyst Thomas Smith downgrades Equillium from Outperform to Market Perform and lowers the price target from $3 to $1.
Equillium Announces Results of the Phase 3 EQUATOR Study of Itolizumab in First-Line Treatment of Patients with Acute Graft-Versus-Host Disease
Treatment with itolizumab did not improve complete or overall response rates at Day 29 Itolizumab achieved statistical significance in multiple secondary endpoints demonstrating compelling clinical benefit in
Equillium Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate and Clinical Highlights
Announced topline data from the Phase 3 EQUATOR study in first-line acute graft-versus-host disease Breakthrough Therapy designation and meeting request to discuss potential for Accelerated Approval submitted to FDA,
Actions Connexes
APOS
Apollo Global Management Inc. 7.625% Fixed-Rate Resettable Junior Subordinated Notes due 2053
PRAX
Praxis Precision Medicines Inc.
CINGW
Cingulate Inc. Warrants
MHD
Blackrock MuniHoldings Fund Inc.
HRB
H&R Block Inc.
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.